Legal & General Group’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Buy |
43,010
+176
| +0.4% | +$8.96K | ﹤0.01% | 1933 |
|
|
2025
Q1 | $1.93M | Buy |
42,834
+2,014
| +5% | +$90.7K | ﹤0.01% | 1937 |
|
|
2024
Q4 | $1.69M | Buy |
40,820
+4,622
| +13% | +$191K | ﹤0.01% | 2049 |
|
|
2024
Q3 | $1.41M | Buy |
36,198
+2,013
| +6% | +$78.5K | ﹤0.01% | 2111 |
|
|
2024
Q2 | $1.17M | Buy |
34,185
+5,540
| +19% | +$189K | ﹤0.01% | 2137 |
|
|
2024
Q1 | $720K | Sell |
28,645
-56
| -0.2% | -$1.41K | ﹤0.01% | 2302 |
|
|
2023
Q4 | $847K | Buy |
28,701
+6,057
| +27% | +$179K | ﹤0.01% | 2257 |
|
|
2023
Q3 | $716K | Buy |
22,644
+1,834
| +9% | +$58K | ﹤0.01% | 2305 |
|
|
2023
Q2 | $538K | Buy |
20,810
+13,031
| +168% | +$337K | ﹤0.01% | 2439 |
|
|
2023
Q1 | $187K | Buy |
7,779
+498
| +7% | +$12K | ﹤0.01% | 2616 |
|
|
2022
Q4 | $142K | Hold |
7,281
| – | – | ﹤0.01% | 2722 |
|
|
2022
Q3 | $153K | Buy |
7,281
+698
| +11% | +$14.7K | ﹤0.01% | 2705 |
|
|
2022
Q2 | $128K | Buy |
6,583
+6,296
| +2,194% | +$122K | ﹤0.01% | 2785 |
|
|
2022
Q1 | $6K | Hold |
287
| – | – | ﹤0.01% | 3488 |
|
|
2021
Q4 | $5K | Hold |
287
| – | – | ﹤0.01% | 3547 |
|
|
2021
Q3 | $6K | Sell |
287
-65
| -18% | -$1.36K | ﹤0.01% | 3473 |
|
|
2021
Q2 | $6K | Sell |
352
-142
| -29% | -$2.42K | ﹤0.01% | 3457 |
|
|
2021
Q1 | $10K | Hold |
494
| – | – | ﹤0.01% | 3379 |
|
|
2020
Q4 | $9K | Hold |
494
| – | – | ﹤0.01% | 3369 |
|
|
2020
Q3 | $9K | Sell |
494
-324
| -40% | -$5.9K | ﹤0.01% | 3268 |
|
|
2020
Q2 | $16K | Hold |
818
| – | – | ﹤0.01% | 3158 |
|
|
2020
Q1 | $11K | Buy |
818
+267
| +48% | +$3.59K | ﹤0.01% | 3132 |
|
|
2019
Q4 | $14K | Buy |
+551
| New | +$14K | ﹤0.01% | 3251 |
|